Related references
Note: Only part of the references are listed.Myxoid hepatocellular adenoma, a rare variant of hepatocellular adenoma with distinct imaging features: A case report with immunohistochemical and molecular analysis and literature review
Nicolas De Vos et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2021)
Applying criteria for hepatocellular neoplasm of uncertain malignant potential reclassifies more than half of hepatocellular adenomas
Brent K. Larson et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2021)
Hepatocellular adenoma, approximately half and predominantly inflammatory subtype, in 38 Japanese patients with several differences in age, gender, and clinical background factors from Western populations
Asami Izu et al.
HEPATOLOGY RESEARCH (2021)
Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-mutated Hepatocellular Adenomas
Christine Sempoux et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Hepatocellular neoplasms arising in genetic metabolic disorders: steatosis is common in both the tumor and background liver
Lin Cheng et al.
HUMAN PATHOLOGY (2021)
Morphologic and Molecular Findings in Myxoid Hepatic Adenomas
Daniel J. Rowan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Hepatocellular Adenoma Risk Factors of Hemorrhage: Size Is Not the Only Concern! Single-center Retrospective Experience of 261 Patients
Celine Julien et al.
ANNALS OF SURGERY (2021)
Does Argininosuccinate Synthase 1 (ASS1) Immunohistochemistry Predict an Increased Risk of Hemorrhage for Hepatocellular Adenomas?
Heidi D. Lehrke et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2020)
Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon
Juan Putra et al.
MODERN PATHOLOGY (2020)
Hepatocellular adenoma in Taiwan: Distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype
Wen-Chih Huang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
New insights in the management of Hepatocellular Adenoma
Anne J. Klompenhouwer et al.
LIVER INTERNATIONAL (2020)
ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice
Margaux Sala et al.
HEPATOLOGY COMMUNICATIONS (2020)
Unclassified hepatocellular adenoma with histological brown pigment deposition and serum PIVKA-II level elevation: a case report
Kouki Hoshino et al.
SURGICAL CASE REPORTS (2020)
Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA
Jaclyn F. Hechtman et al.
HUMAN PATHOLOGY (2019)
Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
Yu Jiang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis
Dai-Min Xiang et al.
GUT (2018)
Atypical Hepatocellular Neoplasms: Review of Clinical, Morphologic, Immunohistochemical, Molecular, and Cytogenetic Features
Won-Tak Choi et al.
ADVANCES IN ANATOMIC PATHOLOGY (2018)
MR imaging of hepatocellular adenomas on genotype-phenotype classification: A report from China
Heqing Wang et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
Hedgehog signalling in liver pathophysiology
Mariana Verdelho Machado et al.
JOURNAL OF HEPATOLOGY (2018)
Systemic AA Amyloidosis Caused by Inflammatory Hepatocellular Adenoma
Julien Calderaro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Molecular classification of hepatocellular adenomas: impact on clinical practice
Anne-Laure Vedie et al.
HEPATIC ONCOLOGY (2018)
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation
Jean-Charles Nault et al.
GASTROENTEROLOGY (2017)
Argininosuccinate Synthase 1 (ASS1): A Marker of Unclassified Hepatocellular Adenoma and High Bleeding Risk
Elodie Henriet et al.
HEPATOLOGY (2017)
The role of autophagy in hepatocellular carcinoma: friend or foe
Lian Liu et al.
ONCOTARGET (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis
Julien Calderaro et al.
MODERN PATHOLOGY (2016)
Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis
Elizabeth Margolskee et al.
DIAGNOSTIC PATHOLOGY (2016)
Genotype-Phenotype Correlation of CTNNB1 Mutations Reveals Different β-Catenin Activity Associated With Liver Tumor Progression
Sandra Rebouissou et al.
HEPATOLOGY (2016)
EASL Clinical Practice Guidelines on the management of benign liver tumours
Massimo Colombo et al.
JOURNAL OF HEPATOLOGY (2016)
Myxoid hepatocellular neoplasms: imaging appearance of a unique mucinous tumor variant
Jesse T. Young et al.
ABDOMINAL RADIOLOGY (2016)
Primary Hepatic Tumors With Myxoid Change Morphologically Unique Hepatic Adenomas and Hepatocellular Carcinomas
Safia N. Salaria et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Pigmented well-differentiated hepatocellular neoplasm with β-catenin mutation
Lara Neves Souza et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2015)
Clinicopathological characteristics of serum amyloid A-positive hepatocellular neoplasms/nodules arising in alcoholic cirrhosis
Motoko Sasaki et al.
HISTOPATHOLOGY (2015)
Pigmented hepatocellular adenomas have a high risk of atypia and malignancy
Taofic Mounajjed et al.
MODERN PATHOLOGY (2015)
Hepatocellular Carcinoma Arising in an HNF-1α-Mutated Adenoma in a 23-Year-Old Woman with Maturity-Onset Diabetes of the Young: A Case Report
Ashley E. Stueck et al.
SEMINARS IN LIVER DISEASE (2015)
Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of -catenin
Toshio Fukusato et al.
HEPATOLOGY RESEARCH (2015)
ACG Clinical Guideline: The Diagnosis and Management of Focal Liver Lesions
Jorge A. Marrero et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Genomic Profiling of Hepatocellular Adenomas Reveals Recurrent FRK-Activating Mutations and the Mechanisms of Malignant Transformation
Camilla Pilati et al.
CANCER CELL (2014)
Well-differentiated hepatocellular neoplasm of uncertain malignant potential: proposal for a new diagnostic category
Pierre Bedossa et al.
HUMAN PATHOLOGY (2014)
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2013)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
Hepatocellular adenoma in glycogen storage disorder type I: a clinicopathological and molecular study
Stratigoula Sakellariou et al.
HISTOPATHOLOGY (2012)
Characterization of hepatocellular adenoma based on the phenotypic classification: The Kanazawa experience
Motoko Sasaki et al.
HEPATOLOGY RESEARCH (2011)
Hepatocellular Adenomas: Current Update on Genetics, Taxonomy, and Management
Alampady Shanbhogue et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2011)
IL-6/gp130/STAT3 signaling axis in cancer and the presence of in-frame gp130 somatic deletions in inflammatory hepatocellular tumors
Rafael Rosell et al.
FUTURE ONCOLOGY (2009)
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
Sandra Rebouissou et al.
NATURE (2009)
Autocrine IL-6 signaling: A key event in tumorigenesis?
Sergei Grivennikov et al.
CANCER CELL (2008)
Familial liver adenomatosis associated with hepatocyte nuclear factor 1α inactivation
Y Bacq et al.
GASTROENTEROLOGY (2003)
Bi-allelic inactivation of TCF1 in hepatic adenomas
O Bluteau et al.
NATURE GENETICS (2002)
P53 gene and wnt signaling in benign Neoplasms:: β-Catenin mutations in hepatic adenoma but not in focal nodular hyperplasia
YW Chen et al.
HEPATOLOGY (2002)
Share Paper
